Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Alam

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Reproductive Biomedicine Online|January 7, 2003
Luteal phase supportVeronica Alam, Margarita Vega, Francisco Rísquez
Fertility and Sterility|August 20, 2008
Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failurePeter R Brinsden, Veronica Alam, Beatrice de Moustier, et al.
Frontiers in Endocrinology|July 24, 2019
The Development of Gonadotropins for Clinical Use in the Treatment of InfertilityBruno Lunenfeld, Wilma Bilger, Salvatore Longobardi, et al.
The Journal of Reproductive Medicine|March 4, 2011
Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysisDavid W Warne, Donald Tredway, Joan C Schertz, et al.
Molecular Genetics and Metabolism Reports|September 14, 2016
The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UKAnita MacDonald, T Alexander Smith, Shamika de Silva, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Reproductive Biomedicine Online|January 7, 2003
Luteal phase supportVeronica Alam, Margarita Vega, Francisco Rísquez
Fertility and Sterility|August 20, 2008
Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failurePeter R Brinsden, Veronica Alam, Beatrice de Moustier, et al.
Frontiers in Endocrinology|July 24, 2019
The Development of Gonadotropins for Clinical Use in the Treatment of InfertilityBruno Lunenfeld, Wilma Bilger, Salvatore Longobardi, et al.
The Journal of Reproductive Medicine|March 4, 2011
Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysisDavid W Warne, Donald Tredway, Joan C Schertz, et al.
Molecular Genetics and Metabolism Reports|September 14, 2016
The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UKAnita MacDonald, T Alexander Smith, Shamika de Silva, et al.
Pageof 1